Trading: HOLD @ $65.75
Signal Strength: MEDIUM
Orthofix (NASDAQ:OFIX) current accumulation has given strength to the share price and the continuation of bullish trading conditions. Currently, the ADLINE is 55502. day. During the quarter, the highest ADLINE value was 75300.1.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
Accumulation/distribution (ADLINE) is a momentum indicator that attempts to gauge supply and demand by determining whether investors are generally accumulating or buying or distributing or selling a certain stock by identifying divergences between stock price and volume flow. The accumulation/distribution is calculated by first calculating the money flow multiplier then multiplying the money flow multiplier by the period’s volume.
Calculation: Accumulation Distribution Line:
1) Money Flow Multiplier = [(close - low) - (high - close)] / (high - low);
2) Money Flow Volume = Money Flow Multiplier x volume for the period;
3) Accumulation/Distribution= previous Accumulation/Distribution + current periods Money Flow Volume.
PROFILE: Orthofix (OFIX)
Stock Exchange: NASDAQ
Ticker Codes: | OFIX | NASDAQ:OFIX |
Orthofix International N.V., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.
|LMAT Lemaitre Vascular||30.77||21.9||828,652||34,237.8||BULLISH|
|LNTH Lantheus Holdings||22.03||15||1,219,888||77,812.8||BULLISH|
|YRCW Yrc Worldwide||8.2||7.5||1,715,718||337,355.5||BULLISH|
|EVBG Everbridge Inc||68.11||6.3||1,328,911||23,097.6||BULLISH|
|ACIU AC Immune||4.21||5||344,667||94,674.4||BULLISH|
|ADMS Adamas Pharma||11.24||4.9||639,718||141,285.9||BULLISH|
|WIRE Encore Wire||57.88||4.7||354,492||20,336.1||BULLISH|
|LSCC Lattice Semicond||11.75||4.6||3,317,074||2,570,096.8||BULLISH|